Issue 9, 2013

Dual-responsive drug release from oligonucleotide-capped mesoporous silica nanoparticles

Abstract

Mesoporous silica nanoparticles (MSNPs) are functionalized with 15-mer single-stranded DNA (ssDNA). After loading of doxorubicin, functionalized MSNPs are capped with 33-mer complementary ssDNA through the formation of double-stranded DNA. Encapsulated doxorubicin could be released by either thermal-triggered denaturization of the DNA capping chains or redox-induced disulfide bond cleavage. An in vitro study shows successful delivery of doxorubicin into HeLa cells.

Graphical abstract: Dual-responsive drug release from oligonucleotide-capped mesoporous silica nanoparticles

Supplementary files

Article information

Article type
Communication
Submitted
09 Apr 2013
Accepted
16 May 2013
First published
10 Jun 2013

Biomater. Sci., 2013,1, 912-917

Dual-responsive drug release from oligonucleotide-capped mesoporous silica nanoparticles

X. Ma, O. S. Ong and Y. Zhao, Biomater. Sci., 2013, 1, 912 DOI: 10.1039/C3BM60090D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements